Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Agios Pharmaceuticals, Inc.](/topic/$agio)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$agio/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% no change  
**1 Month**: XX% +53%  
**6 Months**: XX% +33%  
**1 Year**: XX% -X%  
**1-Year High**: XXX% on 2025-02-22  
**1-Year Low**: XX% on 2025-09-08  

**Most Supportive Themes**
- **Biotech PDUFA Pulse:** (45%) Posts highlighting upcoming FDA decisions and potential catalysts for Agios Pharmaceuticals, Inc. (AGIO).
- **Stock Mentions and Trading:** (30%) Posts mentioning AGIO alongside other stocks, often in the context of trading strategies and potential gains.
  
**Most Critical Themes**
- **PYRUKYND Related Deaths:** (25%)  Mentions of patient deaths associated with the drug PYRUKYND.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Agios Pharmaceuticals, Inc.

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% no change
1 Month: XX% +53%
6 Months: XX% +33%
1 Year: XX% -X%
1-Year High: XXX% on 2025-02-22
1-Year Low: XX% on 2025-09-08

Most Supportive Themes

  • Biotech PDUFA Pulse: (45%) Posts highlighting upcoming FDA decisions and potential catalysts for Agios Pharmaceuticals, Inc. (AGIO).
  • Stock Mentions and Trading: (30%) Posts mentioning AGIO alongside other stocks, often in the context of trading strategies and potential gains.

Most Critical Themes

  • PYRUKYND Related Deaths: (25%) Mentions of patient deaths associated with the drug PYRUKYND.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% XX X%
Total XXX XX% XXX XX% XX X%
Agios Pharmaceuticals, Inc. (AGIO) Sentiment
/topic/$agio/sentiment